Becton Dickinson Price to Sales Ratio 2010-2024 | BDX

Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of November 20, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-11-19 222.64 3.26
2024-06-30 232.78 $68.36 3.41
2024-03-31 245.49 $68.11 3.60
2023-12-31 240.93 $67.61 3.56
2023-09-30 254.43 $68.03 3.74
2023-06-30 258.94 $66.54 3.89
2023-03-31 241.90 $66.13 3.66
2022-09-30 216.11 $65.71 3.29
2022-06-30 238.30 $63.87 3.73
2022-03-31 249.90 $63.79 3.92
2021-12-31 235.49 $63.04 3.74
2021-09-30 229.38 $63.30 3.62
2022-12-31 247.54 $66.70 3.71
2021-06-30 226.21 $63.88 3.54
2021-03-31 225.39 $61.62 3.66
2020-12-31 231.15 $60.36 3.83
2020-09-30 214.21 $57.60 3.72
2020-06-30 219.53 $61.04 3.60
2020-03-31 210.15 $63.37 3.32
2019-12-31 247.89 $63.45 3.91
2019-09-30 229.86 $63.25 3.63
2019-06-30 228.33 $63.21 3.61
2019-03-31 225.53 $62.97 3.58
2018-12-31 202.85 $63.22 3.21
2018-09-30 234.20 $61.44 3.81
2018-06-30 214.34 $58.96 3.64
2018-03-31 193.25 $57.09 3.38
2017-12-31 190.26 $54.93 3.46
2017-09-30 173.57 $54.96 3.16
2017-06-30 172.19 $55.65 3.09
2017-03-31 161.28 $56.62 2.85
2016-12-31 144.98 $57.15 2.54
2016-09-30 156.70 $57.54 2.72
2016-06-30 147.31 $57.43 2.57
2016-03-31 131.36 $57.23 2.30
2015-12-31 132.73 $53.33 2.49
2015-09-30 113.78 $49.93 2.28
2015-06-30 120.95 $46.32 2.61
2015-03-31 122.09 $42.76 2.86
2014-12-31 117.83 $42.99 2.74
2014-09-30 95.96 $42.75 2.24
2014-06-30 99.28 $42.16 2.35
2014-03-31 97.80 $41.54 2.35
2013-12-31 91.86 $41.14 2.23
2013-09-30 82.74 $40.49 2.04
2013-06-30 81.35 $39.35 2.07
2013-03-31 78.30 $38.66 2.03
2012-12-31 63.68 $37.76 1.69
2012-09-30 63.57 $36.66 1.73
2012-06-30 60.13 $35.51 1.69
2012-03-31 62.08 $34.60 1.79
2011-12-31 59.39 $33.93 1.75
2011-09-30 57.91 $33.42 1.73
2011-06-30 67.72 $31.93 2.12
2011-03-31 62.27 $30.88 2.02
2010-12-31 65.76 $29.83 2.20
2010-09-30 57.37 $29.61 1.94
2010-06-30 52.07 $29.83 1.75
2010-03-31 60.31 $29.55 2.04
2009-12-31 60.12 $29.10 2.07
2009-09-30 52.92 $40.12 1.32
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36